Cargando…
Intralesional bivalent and quadrivalent human papillomavirus vaccines didn’t significantly enhance the response of multiple anogenital warts when co-administered with intralesional Candida antigen immunotherapy. A randomized controlled trial
Treatment of anogenital warts (AGWs) is challenging. Candida antigen immunotherapy has been proven to be a safe and relatively effective therapeutic modality; nevertheless, some patients may experience a partial or no response. Combining Candida antigen with other immunotherapies has been proposed t...
Autores principales: | Fawzy, Manal, Nofal, Eman, Abdelkhalek, Naglaa, Ehab, Rana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615931/ https://www.ncbi.nlm.nih.gov/pubmed/37573268 http://dx.doi.org/10.1007/s00403-023-02698-z |
Ejemplares similares
-
Predictors of the Therapeutic Response to Intralesional Bivalent HPV Vaccine in Wart Immunotherapy
por: Hammad, Noha M., et al.
Publicado: (2021) -
Intralesional Candida albicans antigen versus intralesional zinc sulfate in treatment of cutaneous warts
por: Youssef, Eman M. Kamal, et al.
Publicado: (2022) -
Success of Intralesional Purified Protein Derivative Immunotherapy in the Treatment of Anogenital Warts: A Case Report
por: Achdiat, Pati Aji, et al.
Publicado: (2022) -
Triple Intralesional Antigen Immunotherapy versus Monoantigen in the Treatment of Multiple Recalcitrant Warts
por: Nofal, Ahmad A., et al.
Publicado: (2022) -
Switching between intralesional antigens: A promising therapeutic approach for recalcitrant warts
por: Nofal, Ahmad, et al.
Publicado: (2020)